India manufactures a significant share of the world's pharmaceuticals, thanks in part to strict laws against frivolous patents and evergreening. However, a proposed change could make it harder for third parties to object to the granting of patents. This could hurt the Indian pharmaceutical industry as companies shift elsewhere, and drive up prices across the global south in the short term.